Human Vaccines & Immunotherapeutics (Jul 2017)
Realistic fear of cervical cancer risk in Japan depending on birth year
- Asami Yagi,
- Yutaka Ueda,
- Tomomi Egawa-Takata,
- Yusuke Tanaka,
- Ruriko Nakae,
- Akiko Morimoto,
- Yoshito Terai,
- Masahide Ohmichi,
- Tomoyuki Ichimura,
- Toshiyuki Sumi,
- Hiromi Murata,
- Hidetaka Okada,
- Hidekatsu Nakai,
- Masaki Mandai,
- Shinya Matsuzaki,
- Eiji Kobayashi,
- Kiyoshi Yoshino,
- Tadashi Kimura,
- Junko Saito,
- Yumiko Hori,
- Eiichi Morii,
- Tomio Nakayama,
- Yukio Suzuki,
- Yoko Motoki,
- Akiko Sukegawa,
- Mikiko Asai-Sato,
- Etsuko Miyagi,
- Manako Yamaguchi,
- Risa Kudo,
- Sosuke Adachi,
- Masayuki Sekine,
- Takayuki Enomoto,
- Yorihiko Horikoshi,
- Tetsu Takagi,
- Kentaro Shimura
Affiliations
- Asami Yagi
- The OCEAN Study Group (The Obstetrical Gynecological Society of Osaka)
- Yutaka Ueda
- The OCEAN Study Group (The Obstetrical Gynecological Society of Osaka)
- Tomomi Egawa-Takata
- The OCEAN Study Group (The Obstetrical Gynecological Society of Osaka)
- Yusuke Tanaka
- The OCEAN Study Group (The Obstetrical Gynecological Society of Osaka)
- Ruriko Nakae
- The OCEAN Study Group (The Obstetrical Gynecological Society of Osaka)
- Akiko Morimoto
- The OCEAN Study Group (The Obstetrical Gynecological Society of Osaka)
- Yoshito Terai
- The OCEAN Study Group (The Obstetrical Gynecological Society of Osaka)
- Masahide Ohmichi
- The OCEAN Study Group (The Obstetrical Gynecological Society of Osaka)
- Tomoyuki Ichimura
- The OCEAN Study Group (The Obstetrical Gynecological Society of Osaka)
- Toshiyuki Sumi
- The OCEAN Study Group (The Obstetrical Gynecological Society of Osaka)
- Hiromi Murata
- The OCEAN Study Group (The Obstetrical Gynecological Society of Osaka)
- Hidetaka Okada
- The OCEAN Study Group (The Obstetrical Gynecological Society of Osaka)
- Hidekatsu Nakai
- The OCEAN Study Group (The Obstetrical Gynecological Society of Osaka)
- Masaki Mandai
- The OCEAN Study Group (The Obstetrical Gynecological Society of Osaka)
- Shinya Matsuzaki
- The OCEAN Study Group (The Obstetrical Gynecological Society of Osaka)
- Eiji Kobayashi
- The OCEAN Study Group (The Obstetrical Gynecological Society of Osaka)
- Kiyoshi Yoshino
- The OCEAN Study Group (The Obstetrical Gynecological Society of Osaka)
- Tadashi Kimura
- The OCEAN Study Group (The Obstetrical Gynecological Society of Osaka)
- Junko Saito
- The OCEAN Study Group (The Obstetrical Gynecological Society of Osaka)
- Yumiko Hori
- Osaka University Graduate School of Medicine
- Eiichi Morii
- Osaka University Graduate School of Medicine
- Tomio Nakayama
- Osaka Medical Center for Cancer and Cardiovascular Diseases
- Yukio Suzuki
- Yokohama City University Graduate School of Medicine
- Yoko Motoki
- Yokohama City University Graduate School of Medicine
- Akiko Sukegawa
- Yokohama City University Graduate School of Medicine
- Mikiko Asai-Sato
- Yokohama City University Graduate School of Medicine
- Etsuko Miyagi
- Yokohama City University Graduate School of Medicine
- Manako Yamaguchi
- Niigata University Graduate School of Medical and Dental Sciences
- Risa Kudo
- Niigata University Graduate School of Medical and Dental Sciences
- Sosuke Adachi
- Niigata University Graduate School of Medical and Dental Sciences
- Masayuki Sekine
- Niigata University Graduate School of Medical and Dental Sciences
- Takayuki Enomoto
- The OCEAN Study Group (The Obstetrical Gynecological Society of Osaka)
- Yorihiko Horikoshi
- The OCEAN Study Group (The Obstetrical Gynecological Society of Osaka)
- Tetsu Takagi
- The OCEAN Study Group (The Obstetrical Gynecological Society of Osaka)
- Kentaro Shimura
- The OCEAN Study Group (The Obstetrical Gynecological Society of Osaka)
- DOI
- https://doi.org/10.1080/21645515.2017.1292190
- Journal volume & issue
-
Vol. 13,
no. 7
pp. 1700 – 1704
Abstract
Objective: In Japan, the possible adverse events upon HPV vaccination was widely reported in the media. MHLW announced the suspension of aggressively encouraging HPV vaccination in 2013, and inoculation rate has sharply declined. The aim of the present study was estimation of future cervical cancer risk. Methods: The latest data on vaccination rate at each age in Sakai City were first investigated. The rate of experiencing sexual intercourse at the age of 12, 13, 14, 15, 16, 17 and throughout lifetime is assumed to be 0%, 1%, 2%, 5%, 15%, 25%, and 85% respectively. The cervical cancer risk was regarded to be proportional to the relative risk of HPV infection over the lifetime. The risk in those born in 1993 whom HPV vaccination was not available yet for was defined to be 1.0000. Results: The cumulative vaccination rates were 65.8% in those born in 1994, 72.7% in 1995, 72.8% in 1996, 75.7% in 1997, 75.0% in 1998, 66.8% in 1999, 4.1% in 2000, 1.5% in 2001, 0.1% in 2002, and 0.1% in 2003. The relative cervical cancer risk in those born in 1994–1999 was reduced to 0.56–0.70, however, the rate in those born in 2000–2003 was 0.98–1.0, almost the same risk as before introduction of the vaccine. Discussion: The cumulative initial vaccination rates were different by the year of birth. It is confirmed that the risk of future cervical cancer differs in accordance with the year of birth. For these females, cervical cancer screening should be recommended more strongly.
Keywords
- cervical cancer
- governmental suspension of recommendation
- hpv vaccine
- relative risk
- vaccination rate